Dynorphins modulate DNA synthesis in fetal brain cell aggregates

Area of Science:

• Neuroscience
• Molecular Biology
• Developmental Biology

Background:

• Opioid peptides and synthetic opiates inhibit fetal rat brain cell DNA synthesis.
• Kappa- and mu-opioid receptors are implicated in this inhibition.

Purpose of the Study:

• To investigate the effects of dynorphins and other endogenous opioid peptides on DNA synthesis in rat and guinea pig brain cell aggregates.
• To determine the specific opioid receptor subtypes involved in mediating these effects.

Main Methods:

• Cultured 7-day fetal rat and guinea pig brain cell aggregates were treated with various opioid peptides and receptor antagonists.
• DNA synthesis was measured by [3H]thymidine incorporation.
• Dose-dependency studies were conducted for dynorphin B and dynorphin A.

Main Results:

• Dynorphins and beta-endorphin inhibited [3H]thymidine incorporation in 7-day rat brain cell aggregates.
• The kappa-selective antagonist norbinaltorphimine blocked dynorphin-induced inhibition, implicating kappa-opioid receptors.
• Dynorphin B was significantly more potent than dynorphin A, suggesting a specific kappa-receptor subtype.
• Kappa-receptor agonists reduced thymidine incorporation in guinea pig brain cells.
• Dynorphins enhanced thymidine incorporation in 21-day aggregates, a stage with prevalent glial proliferation.

Conclusions:

• Dynorphins modulate glial DNA synthesis during brain development, primarily through kappa-opioid receptors.
• Findings support the hypothesis that dynorphins play a role in regulating glial proliferation in the developing brain.